Edwards Lifesciences (EW) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 42.3 | -0.27 | -0.62 | 23.8 | 32.4 | 33.2 | ||
| Changes by years, y/y, % | -19% | -101% | +131% | -3 951% | +36% | -9.1% | |||
Edwards Lifesciences. EV/EBITDA
Edwards Lifesciences. EV/EBITDA, changes, %
Edwards Lifesciences (EW) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 21.7 | 23.9 | 24.3 | 33.0 | 30.6 | 33.2 | |
| Changes by years, y/y, % | -3 474% | -3 162% | +14% | +43% | +41% | |||
| Changes by quarters, q/q, % | -6% | +10% | +2% | +36% | -7% | |||